Thiol redox barrier; local and systemic surveillance against stress and inflammatory diseases
详细信息    查看全文
文摘
A 12-kDa protein with redox-active dithiol in the active site -Cys-Gly-Pro-Cys-, human thioredoxin 1 (TRX) has demonstrated an excellent anti-inflammatory effect in various animal models. TRX is induced by various oxidative stress factors, including ultraviolet rays, radiation, oxidation, viral infections, ischemia reperfusion and anticancer agents, and are involved in the pathogenesis and progression of various diseases. We have demonstrated that systemic administration and transgenic overexpression of TRX is effective in a wide variety of in vivo inflammatory disease models, such as viral pneumonia, acute lung injury, chronic obstructive pulmonary disease, indomethacin-induced gastric injury, and dermatitis. Our recent studies indicate that topically applied TRX prevents skin inflammation via the inhibition of local formation of inflammatory cytokines and chemokines. These indicate that the activation of inflammasome in skin and mucosa may be regulated by TRX. These suggest that application of TRX may be useful for the treatment of various skin and mucosal inflammatory disorders. Based on these results, we are conducting clinical studies to develop human recombinant thioredoxin 1 (rhTRX) pharmaceuticals. We have also developed substances that increase the expression of TRX in the body (TRX-inducing substances) in vegetables and other plant ingredients, and we are also developing skin-care products and functional foods that take advantage of the anti-inflammation and anti-allergic action of TRX.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700